Skip to main content
Caplight Logo









Vetbiobank

Vetbiobank

Private
FranceHealthcare & Life Scienceshttps://vetbiobank.com/

Last Round

Seed

Aug 3, 2020

Total Funding Raised

$2.66M

Company Overview

Vetbiobank is a biotechnology company that develops and manufactures stem cell-based regenerative therapies to treat chronic inflammatory diseases in companion animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

stem cell therapyallogeneic stem cellsveterinary regenerative medicineanimal stem cell therapycanine osteoarthritismesenchymal stem cellsMSC therapyveterinary biotechnologycell-based drugsvet biotechcompanion animal healthGMP bioproductionanimal healthveterinary pharmaceuticals

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vetbiobank Comparables

Compare Vetbiobank with similar companies based on industry and business-model similarity.

Vetbiobank comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bioceltix
84%
Medrego
83%
eQcell Inc.
83%

Vetbiobank Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 3, 2020
SeedOct 10, 2017
AngelOct 10, 2017

Key People

Founding team and executive leadership

Stephane Maddens

CEO

Executive Team

Vetbiobank Investors

Notable investors and investment history

Vetbiobank investors
InvestorRounds
Health Angels Rhône-AlpesSeed, Angel
SowefundSeed
HolnestSeed
Angels SantéSeed, Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 132% MoM.

  • Oct 20, 2024

    Monthly visitors grew 219% MoM, reaching 619.

Vetbiobank Filings

Explore SEC and related filing metadata, where available.

Vetbiobank filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vetbiobank's valuation, stock price, and market status.

Is Vetbiobank a public or private company?

Vetbiobank is a private company.

What is the current stock price of Vetbiobank?

Vetbiobank is a private company with no public stock price. No recent secondary market data is available.

How much is Vetbiobank worth (valuation)?

Valuation information for Vetbiobank is not publicly available.

Can I buy Vetbiobank stock?

Vetbiobank shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vetbiobank's last funding round?

Vetbiobank's most recent funding round was Seed on August 3, 2020.

Who are the main investors in Vetbiobank?

Key investors in Vetbiobank include Health Angels Rhône-Alpes, Sowefund, Holnest, Angels Santé.

Will Vetbiobank IPO soon?

No public IPO plans have been announced for Vetbiobank.

How can I track Vetbiobank secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vetbiobank's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFrance
Employee Range8
Year Founded2011
Last FundingAug 3, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?